From: Plasma kallistatin levels in patients with severe community-acquired pneumonia
Variables | Survivors (n= 41) | Nonsurvivors (n= 13) | P value |
---|---|---|---|
Age, year | 76 (21-93) | 77 (33-96) | 0.142 |
Gender, male, n (%) | 27 (66) | 7 (54) | 0.652 |
Comorbidities, n (%) | Â | Â | Â |
Diabetes | 8 (20) | 2 (15) | 1.000 |
Chronic kidney disease | 4 (10) | 1 (8) | 1.000 |
Chronic respiratory disease | 7 (17) | 2 (15) | 1.000 |
Liver cirrhosis | 2 (5) | 1 (8) | 1.000 |
Malignancy | 5 (12) | 1 (8) | 1.000 |
ARDS, n (%) | 7 (17) | 7 (54) | 0.025a |
Invasive mechanical ventilation, n (%) | 33 (80) | 13 (100) | 0.176 |
Septic shock at ICU admission, n (%) | 20 (49) | 11 (85) | 0.051b |
Positive blood cultures, n (%) | 7 (17) | 4 (31) | 0.285 |
APACHE II score, points | 18 (6-36) | 25 (14-40) | 0.027a |
SOFA score, points | Â | Â | Â |
   Day 1 | 6 (0-15) | 14 (3-18) | 0.018a |
   Day 4 | 5 (0-18) | 8.5 (2-17) | 0.045a |
CURB-65 score, points | Â | Â | Â |
   Day 1 | 3 (2-5) | 4 (3-5) | 0.002a |
   Day 4 | 3 (0-5) | 4 (1-5) | 0.021a |
ICU stay, days | 9 (3-64) | 13 (2-47) | 0.277 |
Hospital stay, days | 20 (9-64) | 18 (2-52) | 0.302 |
Mechanical ventilation, days | 8 (0-67) | 13 (2-48) | 0.247 |